| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.MAYOCP.2017.04.010 |
| P698 | PubMed publication ID | 28601423 |
| P50 | author | Adam S. Cheifetz | Q67425996 |
| P2093 | author name string | Joseph D Feuerstein | |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| P304 | page(s) | 1088-1103 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | Mayo Clin Proc | Q6538184 |
| P1476 | title | Crohn Disease: Epidemiology, Diagnosis, and Management | |
| P478 | volume | 92 |
| Q92025525 | A Rare Case of Crohn's Disease Manifesting as a Large Liver Abscess |
| Q48191847 | Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease. |
| Q89496265 | Association Between Serological Markers and Crohn's Disease Activity |
| Q58583079 | Association of polymorphic variants in serotonin re-uptake transporter gene with Crohn's disease: a retrospective case-control study |
| Q93101907 | Bryostatin-1 ameliorated experimental colitis in Il-10-/- Mice by protecting the intestinal barrier and limiting immune dysfunction |
| Q60914053 | Burkitt's lymphoma masquerading as a Crohn's flare |
| Q93152010 | Can molecular stratification improve the treatment of inflammatory bowel disease? |
| Q64040052 | Crohn's disease in a developing African mission hospital: a case report |
| Q99929804 | Crohn’s disease |
| Q91893668 | Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia |
| Q90681659 | Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database |
| Q95272558 | Identification of Immune Cell Landscape and Construction of a Novel Diagnostic Nomogram for Crohn's Disease |
| Q93148432 | Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis |
| Q64121962 | Infliximab in inflammatory bowel disease |
| Q58595621 | Lipid and Bile Acid Dysmetabolism in Crohn's Disease |
| Q60302346 | Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease |
| Q64060333 | Outcome of no oral antibiotic prophylaxis and bowel preparation in Crohn's diseases surgery |
| Q93075393 | Pathogenesis of fibrostenosing Crohn's disease |
| Q90473932 | Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn's Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States |
| Q101226502 | Prognostic significance of the Controlling Nutritional Status (CONUT) score in predicting postoperative complications in patients with Crohn's disease |
| Q88599120 | Risk factors for early postoperative complications and length of hospital stay in ileocecal resection and right hemicolectomy for Crohn's disease: a single-center experience |
| Q91802506 | Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases |
| Q39404449 | Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives |
| Q64235979 | Traditional Chinese medicine for management of recurrent and refractory Crohn disease: A case report |
| Q89450140 | Whole transcriptional analysis identifies markers of B, T and plasma cell signaling pathways in the mesenteric adipose tissue associated with Crohn's disease |
| Q90542917 | siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease |
| Q94076162 | siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease |
Search more.